Skip to Main Content

NISH (NITAG Support Hub) 7: Mpox vaccines: Domain 4: Availability of Vaccine

This Library Guide is a collection of useful documents & evidence on the efficacy, effectiveness and impact of MPox vaccines to support NITAG members and other policy makers throughout Africa with making evidence-based recommendations.

Keywords

Mpox AND “availability of vaccine” OR “resource use” OR cost-effectiveness

PubMed

Savinkina, A., Kindrachuk, J., Bogoch, I. I., Rimoin, A. W., Hoff, N. A., Shaw, S. Y., Pitzer, V. E., Mbala-Kingebeni, P., & Gonsalves, G. S. (2024). Modelling vaccination approaches for mpox containment and mitigation in the Democratic Republic of the Congo. The Lancet. Global health, 12(12), e1936–e1944. DOI: 10.1016/S2214-109X(24)00384-X

Mshenga, M. M., Mussa, I. A., & Haji, S. H. (2024). Public health response to Mpox: Safeguarding vulnerable Key Populations and People Living with HIV in Zanzibar. AIDS research and therapy, 21(1), 65.  DOI: 10.1186/s12981-024-00658-9

CDC

CDC. 2024. Mpox.  https://www.cdc.gov/mpox/outbreaks/2022/index-1.html

CDC. 2024. Emergency Preparedness and Response. Mpox Caused by Human-to-Human Transmission of Monkeypox Virus in the Democratic Republic of the Congo with Spread to Neighboring Countries. https://emergency.cdc.gov/han/2024/han00513.asp

CDC. 2024. Clade I Mpox Outbreak Originating in Central Africa.  https://www.cdc.gov/mpox/outbreaks/2023/index.html

WHO

WHO (2022). Vaccines and immunization for monkeypox: Interim guidance. https://www.who.int/publications/i/item/WHO-MPX-Immunization

WHO (2022). Mpox outbreak. https://www.who.int/emergencies/situations/monkeypox-oubreak-2022/1000

WHO (2024). Strategic Advisory Group of Experts (SAGE) on Immunization Evidence to recommendations framework Outbreak response. https://cdn.who.int/media/docs/default-source/immunization/sage/vpp-background-documents/mpox/mpox_grade_and_evidence_to_decision_tables.pdf?sfvrsn=7a10ca01_1

Nature

Kozlov, M. (2022). Monkeypox in Africa: the science the world ignored. Nature, 607(7917), 17-.https://acrobat.adobe.com/id/urn:aaid:sc:EU:745aa0bb-5826-419f-b331-7ba18e22892f

Kozlov, M. (2024). Mpox vaccine roll-out begins in Africa: what will success look like?. Nature. https://acrobat.adobe.com/id/urn:aaid:sc:EU:38a379f4-2fc8-4792-bf19-6aaef352ed80

 

Google Scholar

Abubakar, I., Lutwama, J., Kyobutungi, C., & Sankoh, O. (2024). Mpox global emergency: strengthening African leadership. Lancet, 404(10460), 1286-1288. https://doi.org/10.1016/S0140-6736(24)02068-3

Adelakun, A. A., Onaolapo, M. C., Olorunsesan, M. D., Oluwole, F., & Ajayi, A. F. (2024). Mpox: lessons learnt from previous viral outbreaks applicable to the ongoing outbreak: Mpox: les leçons tirées des précédentes épidémies virales applicables à l'épidémie actuelle. African Journal of Clinical and Experimental Microbiology, 25(4), 371-380.

Albarodi, M. (2024). Mpox vaccine production could put Africa first in line. SciDev. net-Health.

Bakare, D., Salako, J., Sogbesan, A., Olojede, O. E., Akinsola, K. O., Subhi, R., Graham, H., Falade, A., King, C., & Bakare, A. A. (2024). Level of knowledge, and risk perception of Mpox disease among Primary healthcare workers in Nigeria: a cross-sectional study of Jigawa, Oyo and Lagos States. Pan Afr. med. j.

Braimah, J. A., Achore, M., Dery, F., Ayanore, M. A., Bisung, E., & Kuuire, V. (2024). Do self-rated health and previous vaccine uptake influence the willingness to accept MPOX vaccine during a public health emergency of concern? A cross-sectional study. PLOS Glob Public Health, 4(8), e0003564. https://doi.org/10.1371/journal.pgph.0003564

Cevik, M., Tomori, O., Mbala, P., Scagliarini, A., Petersen, E., Low, N., Heymann, D., Lee, S. S., & Blumberg, L. (2024). The 2023–2024 multi-source mpox outbreaks of Clade I MPXV in sub-Saharan Africa: alarm bell for Africa and the World. International Journal of Infectious Diseases, 146.

Delight, E. A., Brunn, A. A., Ruiz, F., Gerard, J., Falconer, J., Liu, Y., Bah, B., Bett, B., Uzochukwu, B., & Oloko, O. K. (2024). Gaps and Opportunities for Data Systems and Economics to Support Priority Setting for Climate-Sensitive Infectious Diseases in Sub-Saharan Africa: A Rapid Scoping Review. medRxiv, 2024-2009.

Guillaume, A. S., Ndwandwe, D., Nyalundja, A. D., Bugeme, P. M., Ntaboba, A. B., Hatu'm, V. U., Tamuzi, J. L., Iwu-Jaja, C., Shindano, T. A., Wiysonge, C. S., & Katoto, P. (2024). Caregivers' hesitancy and outright refusal toward children's COVID-19 vaccination in the Democratic Republic of Congo: A community-based cross-sectional study. Hum Vaccin Immunother, 20(1), 2422686. https://doi.org/10.1080/21645515.2024.2422686

Hrynick, T., & Schmidt-Sane, M. (2024). Roundtable report: Discussion on mpox in DRC and social science considerations for operational response.

Lawrence, A. (2024). Assessing Vaccine Intentions, Knowledge, Self-Efficacy, and Trust: A Cross-Sectional Study on Perceptions of Monkeypox Vaccination and Public Health Risk Awareness in Makurdi, Benue State, Nigeria. Cureus, 16(10), e72131. https://doi.org/10.7759/cureus.72131

Lee, S. S., Traore, T., & Zumla, A. (2024). The WHO mpox public health emergency of international concern declaration: Need for reprioritisation of global public health responses to combat the MPXV Clade I epidemic. Int J Infect Dis, 147, 107227. https://doi.org/10.1016/j.ijid.2024.107227

Lieber, W. C., Rahim, F. O., Lartey, H. S. Q., Shah, D., Mmbaga, B. T., Thielman, N. M., & Hertz, J. T. (2024). Capacity building for infectious disease control in Sub-Saharan Africa. Pathog Glob Health, 118(6), 526-528. https://doi.org/10.1080/20477724.2023.2272363

Mektebi, A., Elsaid, M., Yadav, T., Abdallh, F., Assker, M., Siddiq, A., Sayad, R., Saifi, M., & Farahat, R. A. (2024). Mpox vaccine acceptance among healthcare workers: a systematic review and meta-analysis. BMC Public Health, 24(1), 4. https://doi.org/10.1186/s12889-023-17186-2

Novacek, A. Mpox vaccine acceptance among men who have sex with men–A secondary data analysis for an online cross-sectional survey in Austria.

Olawade, D. B., Wada, O. Z., Fidelis, S. C., Oluwole, O. S., Alisi, C. S., Orimabuyaku, N. F., & David-Olawade, A. C. Science in One Health.

Phiri, S. J., & Lusaka, Z. Mpox in Zambia: An Overview of Pathogenesis, Diagnosis, and Public Health Implications.

Prochazka, M., Vinti, P., Hoxha, A., Seale, A., Mozalevskis, A., Lewis, R., Sagastume, R. M., Scherzer, M., Dore, L., & Doherty, M. (2024). Temporary adaptations to sexual behaviour during the mpox outbreak in 23 countries in Europe and the Americas: findings from a retrospective cross-sectional online survey. Lancet Infect Dis. https://doi.org/10.1016/S1473-3099(24)00531-0

Rahim, F. O., Fallah, M., Jain, U., Richardson, E. T., Ndembi, N., Ngongo, N., & Kaseya, J. (2024). Challenges and Ongoing Actions to Address the Mpox Emergency in Africa. Ann Glob Health, 90(1), 68. https://doi.org/10.5334/aogh.4580

Sam, S. O., Eleveld, A., Mbala, A., & Rogo, K. (2024). Enormity of Africa’s MPOX data: A comparative analysis. East African Medical Journal, 101(9), 7365-7377.

Samarasekera, U. (2024). Jean Nachega: collaborating for research on mpox in Africa. Lancet, 404(10462), 1511. https://doi.org/10.1016/S0140-6736(24)02267-0

Schmidt-Sane, M., Adegoke, O., Abbas, S., Lawanson, A. O., Kunnuji, M., Jegede, A., & MacGregor, H. (2024). Infrastructures of epidemic response: Mpox and everyday repair work in southwestern Nigeria. Soc Sci Med, 358, 117246. https://doi.org/10.1016/j.socscimed.2024.117246

Schuklenk, U. From COVID‐19 to mpox vaccine hoarding‐Has the Global North learned its global health lessons? In: Wiley Online Library.

Sinumvayo, J. P., Munezero, P. C., Tope, A. T., Adeyemo, R. O., Bale, M. I., Mutsaka-Makuvaza, M. J., Daba, T. M., Nyandwi, J. B., Nzungize, L., & Mutumwinka, D. (2024). Vaccination and vaccine-preventable diseases in Africa. Scientific African, e02199.

Sokunbi, T. O., & Akinbi, E. O. (2024). The cost of the reemergence of monkeypox: An overview of health financing in Africa. Health Policy OPEN, 100132.

Sulaiman, S. K., Isma'il Tsiga-Ahmed, F., Musa, M. S., Makama, B. T., Sulaiman, A. K., & Abdulaziz, T. B. (2024). Global prevalence and correlates of mpox vaccine acceptance and uptake: a systematic review and meta-analysis. Commun Med (Lond), 4(1), 136. https://doi.org/10.1038/s43856-024-00564-1

Telford, E., D’Ortenzio, E., & Yazdanpanah, Y. (2024). A Second Mpox Outbreak in Brazil: A Call for Action to Guarantee Equity in Access to Health Innovations. In (Vol. 79, pp. 660-662): Oxford University Press US.